|
|
|
|
Dune Medical raises $5 million
Medical Devices completes a $5 million (USD) series A financing round led by Apax Partners.
March 29, 2004
|
Tel Aviv/London, UK, March 29, 2004 - Dune Medical Devices Ltd., an Israel-based developer of surgical oncology technologies and products, today announced the closing of its series A funding led by Apex Partners Funds with the participation of the existing seed investors.
Dr. Dan Hashimshony, Dune Medical Devices founder and CEO, said: "Completing this financing will enable Dune Medical Devices to accelerate R&D and bring us closer to turning our unique cutting edge technology into valuable solutions and products in the field of surgical oncology. We are very pleased to have Apax as an investor and value their involvement in the development of our company.
Amos Goren, Partner, Apax Partners Israel, said: "We are very excited about our new investment in Dune and are looking forward to working with these exceptional entrepreneurs. Dune's technology has the potential to revolutionise the surgical treatment of cancer and we are pleased to be part of this endeavour."
Three directors will be appointed to Dune's Board of Directors as part of this investment: Dr. Morry Blumenfeld, who has 34 years of experience in the field as a senior executive at GE Medical, Guy Shinar, former CEO of X-Technologies, and Amos Goren, Head of Apax Partners' European Healthcare team.
For more information contact:
Gil Rosen, VP Business Development
tel: (972) 4 617-8000
email: gil@dunemedical.com
|
|
|
|
|
